BREVE REVISÃO SOBRE PARASITOSES EMERGENTES
DOI:
https://doi.org/10.56238/rebeisv1n7-006Palavras-chave:
Parasitoses emergentes, saneamento e prevençãoResumo
As parasitoses emergentes continuam a ser um desafio de saúde pública global, exacerbadas pela mudança climática, urbanização e globalização. Neste artigo, discutiremos as principais parasitoses emergentes, incluindo a estrongiloidíase, a doença de Chagas, a leishmaniose, a toxoplasmose, a echinococose, a angiostrongilíase, a malária e a esquistossomose, apresentando suas características epidemiológicas, fatores determinantes e implicações para a saúde pública. O objetivo desta revisão é fornecer uma análise abrangente sobre essas infecções parasitárias e sugerir estratégias para seu controle e prevenção.
Referências
Alvar, J., Velez, I. D., Bern, C., et al. (2012). Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE, 7(5), e35671.
Baily, J. A., et al. (2015). Echinococcosis: a review of the epidemiology and control measures. Journal of Helminthology, 89(4), 479-491.
Baker, J. R., & Rojas, C. (2020). Emerging parasitic zoonoses and public health implications. Emerging Infectious Diseases, 26(5), 980-989.
Baker, J., et al. (2017). Strongyloides stercoralis: a neglected parasite in the US. The American Journal of Medicine, 130(11), 1300.
Chalmers, R. M., & Katzer, F. (2013). Cryptosporidium: parasites, prevention and control. Infectious Disease Clinics of North America, 27(3), 545-570.
Cohen, J. E., et al. (2017). Schistosomiasis: Assessing the efficacy of praziquantel and how to address drug resistance. Nature Reviews Microbiology, 15(1), 11-29.
D’Avila-Levy, C. M., et al. (2015). The role of environmental and socio-demographic factors in the emergence of leishmaniasis. Trends in Parasitology, 31(5), 251-262.
Flegr, J., et al. (2015). Toxoplasmosis and its impact on human health. Journal of Infection and Public Health, 8(6), 659-666.
Githeko, A. K., Lindsay, S. W., Confalonieri, U. E., & Patz, J. A. (2000). Climate change and vector-borne diseases: a regional analysis. Environmental Health Perspectives, 108(Suppl 2), 175-184.
Havelková, B., et al. (2021). Toxoplasmosis: epidemiology and food borne transmission. Foodborne Pathogens and Disease, 18(4), 237-247.
Hotez, P. J., Bottazzi, M. E., Franco-Paredes, C., Ault, S. K., & Periago, M. R. (2008). The neglected tropical diseases of Latin America and the Caribbean: A review of disease burden and distribution and a roadmap for control and elimination. PLoS Neglected Tropical Diseases, 2(9), e300. DOI: 10.1371/journal.pntd.0000300
Hotez, P. J., Alvarado, M., Basáñez, M. G., Bolliger, I., Bourne, R., Boussinesq, M., ... & Murray, C. J. (2014). The global burden of disease study 2010: Interpretation and implications for the neglected tropical diseases. PLoS Neglected Tropical Diseases, 8(7), e2865. DOI: 10.1371/journal.pntd.0002865
Liu, Q., et al. (2020). Angiostrongylus cantonensis: an overview of a potential threat for human health. Frontiers in Microbiology, 11, 179.
Lysenko, A. A., et al. (2020). Epidemiology of strongyloidiasis in different geographical regions of the world. Wiener Klinische Wochenschrift, 132(21-22), 697-706.
Montoya, J. G., & Liesenfeld, O. (2004). Toxoplasmosis. Lancet, 363(9425), 1965-1976.
Moraes, C. B., et al. (2020). Epidemiological aspects and prognosis of Chagas disease in patients receiving treatment. International Journal of Infectious Diseases, 95, 293-299.
Patz, J. A., Campbell-Lendrum, D., Holloway, T., & Foley, J. A. (2005). Impact of regional climate change on human health. Nature, 438(7066), 310-317. DOI: 10.1038/nature04188
Panais, A., Michopoulou, E., & Hatzidimitriou, D. (2020). Toxoplasma gondii and public health: a growing concern. Parasitology Research, 119(1), 15-21.
Qian, H., et al. (2018). Angiostrongylus cantonensis: A public health concern. Journal of Microbiology and Biotechnology, 34(1), 160-168.
Ravindran, R., et al. (2017). Chagas disease—an emerging global health challenge. Nature Reviews Disease Primers, 3, 17016.
Rokicki, J., et al. (2020). Echinococcosis: a neglected but treatable disease. Nature Reviews Disease Primers, 6, 1-13.
Rohou, S., et al. (2020). Current and future treatments for leishmaniasis: a review. Frontiers in Pharmacology, 11, 780.
Savioli, L., et al. (2016). Schistosomiasis: a global perspective on the epidemiology of infection and disease. Acta Tropica, 165, 172-184.
Schmunis, G. A., et al. (2007). Chagas disease in non-endemic countries: an overview. Tropical Medicine and International Health, 12(2), 223-227.
Stothard, J. R., et al. (2009). Schistosomiasis: constraints of control and the prospect of elimination. Parasitology Today, 13(7), 266-274.
Tarleton, R. L., Reithinger, R., Urbina, J. A., Kitron, U., & Gürtler, R. E. (2007). The challenges of Chagas disease: Grim outlook or glimmer of hope? PLoS Medicine, 4(12), e332. DOI: 10.1371/journal.pmed.0040332
World Health Organization. (2020). World malaria report 2020: 20 years of global progress and challenges. Geneva: World Health Organization. ISBN 978-92-4-001579-1.
Weiss, L. M., et al. (2015). Strongyloides stercoralis: a global perspective on a neglected disease. Clinical Microbiology Reviews, 28(3), 557-582.
Yamamoto, M., et al. (2021). Diagnosis and treatment of strongyloidiasis: a systematic review. Frontiers in Medicine, 7, 87.
Yang, Y. R., et al. (2016). Genetic diversity of Toxoplasma gondii: implications for understanding transmission and public health. Frontiers in Microbiology, 7, 62.
